Key Points
- Director Joseph Konowiecki sold 25,000 shares at an average price of $19.00 on Nov. 25 for proceeds of $475,000, reducing his stake by 2.31% to 1,056,141 shares, per an SEC filing.
- Alignment Healthcare reported Q3 EPS of $0.02, beating estimates, and revenue of $993.7M (up 43.5% YoY) but still shows a negative net margin and ROE; the stock trades around $19 with a consensus “Moderate Buy” and an average price target of $20.05.
Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) Director Joseph Konowiecki sold 25,000 shares of the firm's stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $19.00, for a total value of $475,000.00. Following the sale, the director owned 1,056,141 shares in the company, valued at $20,066,679. This trade represents a 2.31% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Alignment Healthcare Trading Up 0.4%
Shares of ALHC stock opened at $19.22 on Thursday. The stock has a 50 day simple moving average of $17.11 and a 200-day simple moving average of $15.47. Alignment Healthcare, Inc. has a 1-year low of $10.18 and a 1-year high of $21.06. The company has a market cap of $3.85 billion, a price-to-earnings ratio of -160.17 and a beta of 1.17. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings data on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, topping analysts' consensus estimates of ($0.01) by $0.03. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. The company had revenue of $993.70 million during the quarter, compared to analysts' expectations of $980.90 million. During the same period in the prior year, the business posted ($0.14) earnings per share. The firm's revenue for the quarter was up 43.5% on a year-over-year basis. Alignment Healthcare has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. On average, equities research analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on the company. Zacks Research cut Alignment Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, October 28th. JPMorgan Chase & Co. raised shares of Alignment Healthcare from a "neutral" rating to an "overweight" rating and upped their target price for the stock from $18.00 to $20.00 in a report on Monday. KeyCorp reiterated an "overweight" rating on shares of Alignment Healthcare in a research report on Monday. Barclays boosted their price target on shares of Alignment Healthcare from $13.00 to $18.00 and gave the stock an "equal weight" rating in a research report on Friday, October 31st. Finally, The Goldman Sachs Group reiterated a "buy" rating and issued a $22.00 price objective on shares of Alignment Healthcare in a report on Monday, November 3rd. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $20.05.
Read Our Latest Research Report on ALHC
Institutional Trading of Alignment Healthcare
Several institutional investors and hedge funds have recently bought and sold shares of the stock. CIBC Bancorp USA Inc. purchased a new position in Alignment Healthcare during the third quarter worth about $272,000. Maven Securities LTD acquired a new position in shares of Alignment Healthcare in the 3rd quarter worth approximately $872,000. Wilmington Savings Fund Society FSB purchased a new position in shares of Alignment Healthcare during the 3rd quarter worth approximately $53,000. Yorkville Advisors Global LP purchased a new position in shares of Alignment Healthcare during the 3rd quarter worth approximately $1,309,000. Finally, Dark Forest Capital Management LP acquired a new stake in Alignment Healthcare in the 3rd quarter valued at approximately $473,000. 86.19% of the stock is currently owned by hedge funds and other institutional investors.
About Alignment Healthcare
(
Get Free Report)
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
